11 Aug 2017

Billie’s story of giving

When Billie received her leukaemia diagnosis, her response was to find a way to help others.

Billie was diagnosed with acute lymphoblastic leukaemia (ALL) five years ago. She received so much support in response to her leukaemia diagnosis that she set up Billie’s Fund to give something back to the charities that helped her during her treatment.

Supported by her family and friends, Billie’s Fund has raised thousands of pounds and are delighted that Billie has chosen Leukaemia UK as one of Billie’s Fund’s beneficiary charities.

Help Leukaemia UK continue to support people like Billie by donating today.

Read more stories from our community.

Related posts

Our life-saving work must continue

4 August 2020

Our life-saving work must continue

Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue

Together we are changing lives – Here’s how your support is making it happen

3 July 2025

Together we are changing lives – Here’s how your support is making it happen

At this point in our advocacy journey, we wanted to share an update to you, our supporters, on everything we’ve achieved so far and what’s next as we continue to…

Leukaemia UK appoints Hannah Peckham as newest Ambassador

16 November 2023

Leukaemia UK appoints Hannah Peckham as newest Ambassador

Leukaemia UK has today announced its appointment of award-winning children’s book author, Hannah Peckham, as its newest celebrity Ambassador. Hannah joins the likes of actor Dougray Scott, celebrity chef Francesco…

Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award

11 August 2021

Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award

We are delighted to announce the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award has been awarded to Dr Samanta Mariani, in recognition of her innovative research that could contribute significantly to our understanding of leukaemia and other blood cancers.